Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Comorbid Major Depression and Chronic Headache
NCT00531895Phase 4Completed
- Sponsor
- Kraepelin Psiquiatria Clínica
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in major depressive disorder (MDD), chronic migraine, tension-type headache (TTH), sponsored by Kraepelin Psiquiatria Clínica. Started Apr 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)chronic migrainetension-type headache (TTH)
Beyond the preview
Go deeper on NCT00531895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531895.